Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model.

Xie L, Hu LF, Teo XQ, Tiong CX, Tazzari V, Sparatore A, Del Soldato P, Dawe GS, Bian JS.

PLoS One. 2013;8(4):e60200. doi: 10.1371/journal.pone.0060200. Epub 2013 Apr 3.

2.

Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Shin KS, Choi HS, Zhao TT, Suh KH, Kwon IH, Choi SO, Lee MK.

Arch Pharm Res. 2013 Jun;36(6):759-67. doi: 10.1007/s12272-013-0051-4. Epub 2013 Mar 29.

PMID:
23539311
3.

Phloroglucinol attenuates motor functional deficits in an animal model of Parkinson's disease by enhancing Nrf2 activity.

Ryu J, Zhang R, Hong BH, Yang EJ, Kang KA, Choi M, Kim KC, Noh SJ, Kim HS, Lee NH, Hyun JW, Kim HS.

PLoS One. 2013 Aug 20;8(8):e71178. doi: 10.1371/journal.pone.0071178. eCollection 2013.

4.

Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models.

Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, Bian JS.

Aging Cell. 2010 Apr;9(2):135-46. doi: 10.1111/j.1474-9726.2009.00543.x. Epub 2009 Dec 23.

5.

Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.

Chagniel L, Robitaille C, Lebel M, Cyr M.

Neurobiol Dis. 2012 Jan;45(1):645-55. doi: 10.1016/j.nbd.2011.10.011. Epub 2011 Oct 19.

PMID:
22037042
6.

Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.

Guo B, Xu D, Duan H, Du J, Zhang Z, Lee SM, Wang Y.

Biol Pharm Bull. 2014;37(2):274-85. Epub 2013 Dec 3.

7.

[Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].

Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H.

Zhongguo Zhong Yao Za Zhi. 2014 May;39(9):1660-5. Chinese.

PMID:
25095380
8.

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.

Neurobiol Dis. 2006 May;22(2):421-34. Epub 2006 Feb 9.

PMID:
16480889
10.

Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: Role of NADPH oxidase-1.

Zhang FL, He Y, Zheng Y, Zhang WJ, Wang Q, Jia YJ, Song HL, An HT, Zhang HB, Qian YJ, Tong YL, Dong L, Wang XM.

CNS Neurosci Ther. 2014 Dec;20(12):1036-44. doi: 10.1111/cns.12340. Epub 2014 Nov 15.

PMID:
25399812
11.
12.

Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease.

Du XX, Xu HM, Jiang H, Song N, Wang J, Xie JX.

Neurosci Bull. 2012 Jun;28(3):253-8. doi: 10.1007/s12264-012-1238-2.

14.

Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease.

Prinz A, Selesnew LM, Liss B, Roeper J, Carlsson T.

Exp Neurol. 2013 Oct;248:236-45. doi: 10.1016/j.expneurol.2013.06.015. Epub 2013 Jun 26.

PMID:
23810738
15.

Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.

Jing X, Shi H, Zhang C, Ren M, Han M, Wei X, Zhang X, Lou H.

Neuroscience. 2015 Feb 12;286:131-40. doi: 10.1016/j.neuroscience.2014.11.047. Epub 2014 Nov 29.

PMID:
25449120
17.

[Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].

Meng JL, Ma YY, Luo HY, Kong SZ, He YW, Dong BC, Wu SH, He M.

Sheng Li Xue Bao. 2008 Jun 25;60(3):369-74. Chinese.

18.

Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models.

Park HJ, Zhao TT, Lee KS, Lee SH, Shin KS, Park KH, Choi HS, Lee MK.

Neurochem Int. 2015 Apr-May;83-84:19-27. doi: 10.1016/j.neuint.2015.01.003. Epub 2015 Mar 3.

PMID:
25747493
20.

Supplemental Content

Support Center